Craig Seaman is a Hematologist in Pittsburgh, Pennsylvania. Dr. Seaman is rated as a Distinguished provider by MediFind in the treatment of Heyde Syndrome. His top areas of expertise are Von Willebrand Disease (VWD), Hemophilia A, Blood Clots, and Hemophilic Arthropathy. Dr. Seaman is currently accepting new patients.

Melissa K. Yee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center.  She specializes in the treatment of solid tumors and blood disorders. Dr. Yee is board-certified by the American Board of Internal Medicine in medical oncology, hematology, and internal medicine.  She received her medical degree from the Drexel University College of Medicine in Philadelphia. She then completed her internal medicine residency and hematology/oncology fellowship at UPMC. She earned her undergraduate degree from Tufts University. After completion of her medical training, she was on staff at Dana Farber Cancer Institute in Boston before returning to Pittsburgh to practice at UPMC Mercy. Dr. Yee is a member of the American Society of Clinical Oncology, American Association for Cancer Research, and American Society of Hematology, and Massachusetts Medical Society. Dr. Yee is rated as an Experienced provider by MediFind in the treatment of Heyde Syndrome. Her top areas of expertise are Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Pleuropulmonary Blastoma.

Nicoletta Machin, DO, specializes in benign hematology and is certified in internal medicine by the American Board of Internal Medicine. She has a special clinical and research interest in inherited bleeding disorders and women's health related to hematologic issues including those impacting pregnancy. She completed her medical degree at the University of New England College of Osteopathic Medicine, followed by a residency and fellowship at the University of Pittsburgh School of Medicine. She practices at the University of Pittsburgh Physicians, Department of Hematology-Oncology, and is affiliated with UPMC Magee-Womens Hospital, UPMC Shadyside, and UPMC Presbyterian. Dr. Machin is rated as an Experienced provider by MediFind in the treatment of Heyde Syndrome. Her top areas of expertise are Hemophilia A, Von Willebrand Disease (VWD), Hemophilia B, Hemophilic Arthropathy, and Hormone Replacement Therapy (HRT).

Roy E. Smith, MD, is a professor of medicine at the University of Pittsburgh School of Medicine in the Division of Hematology/Oncology. Dr Smith specializes in bleeding and thrombotic disorders, Rare Homologic Diseases, Chronic Leukemia and Myelodyplasia. Dr. Smith is board-certified in internal medicine, medical oncology, and hematology. He received his medical degree from The Ohio State University, Columbus, and his Master of Science degree from the University of Wisconsin, College of Medicine, Madison. He completed his residency in medical oncology and his fellowship in hematology oncology, both at The Ohio State University. He is the former director of the Ohio State University Hospital's Special Coagulation Laboratory and its Hemophilia Center. He presently serves as chairman of the Central Investigational Review Board for the Cancer Therapeutics and Development branch of the National Cancer Institute and has served on the Peripheral and Central Nervous System Drug Advisory Committee and the Oncologic Drug Advisory Committee of the FDA. Dr. Smith serves as the co-chair of the Anticoagulation Task Force for the Presbyterian Hospital and its affiliates and chair of the Anticoagulation Working Group of the system-wide P and T committee. Dr. Smith is a member of the American Society of Hematology, the American Society of Clinical Oncology, the Society for Scientific Exploration, The International Society of Thrombosis and Hemostasis, the American Medical Association and the American Society for Apheresis, and the American College of Chest Physicians. He is a Fellow of the American College of Physicians and the International Academy of Clinical and Applied Thrombosis and Hemostasis. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Heyde Syndrome. His top areas of expertise are Venous Thromboembolism (VTE), Acute Hepatic Porphyria (AHP), Shwartzman Phenomenon, and Porphyria.

Rebecca Mancoll, MD, is certified in internal medicine by the American Board of Internal Medicine and is affiliated with UPMC Presbyterian. She completed her residency at the University of Pittsburgh School of Medicine and medical degree at Jefferson Medical College. Dr. Mancoll is rated as an Experienced provider by MediFind in the treatment of Heyde Syndrome. Her top areas of expertise are Heyde Syndrome, Von Willebrand Disease (VWD), Type 2 Diabetes (T2D), and Osteomyelitis in Children.

Margaret Ragni is a Hematologist in Pittsburgh, Pennsylvania. Dr. Ragni is rated as an Advanced provider by MediFind in the treatment of Heyde Syndrome. Her top areas of expertise are Hemophilia A, Blood Clots, Von Willebrand Disease (VWD), Hemophilia B, and Hip Replacement.

Elana Bloom is a Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Bloom is rated as an Advanced provider by MediFind in the treatment of Heyde Syndrome. Her top areas of expertise are Febrile Neutropenia, Heyde Syndrome, Von Willebrand Disease (VWD), and Hereditary Resistance to Anti-Vitamin K.

John C. Rhee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Rhee is skilled in the management of all forms of cancer and blood diseases, with particular interest in cancers of the gastrointestinal tract and chest, including colorectal, esophageal, gastric, pancreaticobiliary, liver, neuroendocrine, and lung tumors. Dr. Rhee is rated as an Experienced provider by MediFind in the treatment of Heyde Syndrome. His top areas of expertise are Colorectal Cancer, Familial Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Gamma Knife Radiosurgery, and Gastrostomy.

Jing-Zhou Hou, MD, PhD, is a clinical hematological oncologist specializing in hematological malignancies, cell therapy, and bone marrow transplant in the Mario Lemieux Center for Blood Cancers at UPMC Hillman Cancer Center. Dr. Hou received his medical degree from Henan Medical University in China, his master’s degree at Shanghai Medical University, and his PhD in Molecular and Cell Biology from Tulane University. He completed his internal medicine residency in Northeastern Ohio University College of Medicine, and fellowship in Hematology and Oncology at Stanford University. He joined UPMC Hillman Cancer Center in 2007. Dr. Hou is rated as an Experienced provider by MediFind in the treatment of Heyde Syndrome. His top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Robert VanderWeele, MD, MS, is a hematologist/medical oncologist at UPMC Hillman Cancer Center. He specializes in cytopenias, bleeding and clotting disorders, leukemia, lymphoma, myeloma, GI malignancies, breast cancer, lung cancer, and prostate cancer. Dr. Vanderweele is rated as an Experienced provider by MediFind in the treatment of Heyde Syndrome. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, Adult Immune Thrombocytopenia, and Hemangioma Thrombocytopenia Syndrome.

Min Sun, MD, PhD, is an oncologist and hematologist at UPMC. He specializes in the clinical care of breast cancer patients and those at high-risk for breast cancer. He also researches breast cancer tumor markers and early diagnosis. Dr. Sun is rated as an Experienced provider by MediFind in the treatment of Heyde Syndrome. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Familial Colorectal Cancer.

Andrew D. Laman, MD, is a hematologist and oncologist at UPMC Hillman Cancer Center. Dr. Laman specializes in hematology and medical oncology. Dr. Laman is rated as an Experienced provider by MediFind in the treatment of Heyde Syndrome. His top areas of expertise are Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Squamous Cell Lung Carcinoma.

Jennifer Osborn, MD, specializes in hematology oncology and is board-certified in medical oncology by the American Board of Internal Medicine. She practices at UPMC Hillman Cancer Center at UPMC Passavant-McCandless and UPMC Hillman Cancer Center at UPMC Passavant-Cranberry and is affiliated with UPMC Passavant and UPMC Magee-Womens Hospital. Dr. Osborn received her medical degree from The Ohio State University College of Medicine and completed her residency and fellowship at the University of Pittsburgh School of Medicine. Dr. Osborn is rated as an Experienced provider by MediFind in the treatment of Heyde Syndrome. Her top areas of expertise are Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Breast Cancer.

Mark Georgiadis is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Georgiadis is rated as an Experienced provider by MediFind in the treatment of Heyde Syndrome. His top areas of expertise are Pleuropulmonary Blastoma, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Non-Hodgkin Lymphoma, and Gastric Lymphoma.

Dhaval R. Mehta, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Mehta treats all types of cancer and has special interest in hematological disorders and solid tumors, and clinical trials in the community setting. Dr. Mehta is rated as an Experienced provider by MediFind in the treatment of Heyde Syndrome. His top areas of expertise are Polycythemia Vera, Paget Disease of the Breast, Familial Pancreatic Cancer, and Neuroendocrine Tumor.

Khanh Nguyen, MD, specializes in medical oncology and practices with UPMC Hillman Cancer Center and is affiliated with UPMC East and UPMC Magee-Womens Hospital. Dr. Nguyen completed his medical education at the Medical College of Georgia and is board certified in Medical Oncology by the American Board of Internal Medicine. Dr. Nguyen is rated as an Experienced provider by MediFind in the treatment of Heyde Syndrome. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, and Breast Cancer.